Filter posts

“A Transformative Year in Medicine”

2017 will be remembered as an exciting year for biopharmaceutical innovation. Not only did we …

Five Questions for the Senate Hearing on Prescription Drugs

On Tuesday, the Senate Committee on Health, Education, Labor, and Pensions will hold its third …

Jim Greenwood Talks Biotech Innovation With Bloomberg Radio

While in Boston this week, BIO CEO Jim Greenwood sat down with Bloomberg Boston Bureau …

What's Driving Health Care Spending? Hint: Not Drug Costs.

With health care costs an important concern for many Americans, a common misperception is the …

New Infographic: The Bayh-Dole Act

$1.3 trillion in economic output. Support for roughly 4.2 million jobs. The creation of more …

ICYMI: Jim Greenwood Weighs In on the Future of Drug Pricing

Rewarding for quality – not quantity – is becoming more and more common in health …

Insurer Shifting Blame for Rising Premiums

According to a new report from Chad Terhune with Kaiser Health News, insurance giant Anthem …

California Senate Passed Drug Price Reporting & Transparency Bill

This week the California Senate passed a tremendously flawed bill that would hamper the ability …

ICYMI: Drug Pricing Bill Is Bad for Business, Patients

Researchers and biotech leaders continue to discover new cures and treatments that are making a …

Op-Ed from Cancer Patient Warns: Don’t Sacrifice Cures Through Price Transparency

Deborah Goldberg’s op-ed to The Sacramento Bee recounts her three-year battle with colon cancer. She …